Bolt Biotherapeutics (BOLT) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bolt Biotherapeutics (NASDAQ:BOLT) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comHER2 Positive Breast Cancer Treatment Pipeline Landscape 2024: Insight Report Reveals Over 60 Companies Developing Innovative TherapiesSeptember 25, 2024 | finance.yahoo.comA Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc Has Been Filed And The Schall Law Firm Wants Investors To Reach OutAugust 24, 2024 | stockhouse.comHold Rating on Bolt Biotherapeutics Pending Clarity on Clinical Pipeline and Efficacy DataAugust 15, 2024 | markets.businessinsider.comBOLT Stock Earnings: Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024August 13, 2024 | markets.businessinsider.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BoltAugust 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Evolus (EOLS) and Humana (HUM)August 5, 2024 | markets.businessinsider.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BoltAugust 1, 2024 | markets.businessinsider.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BoltJuly 27, 2024 | stockhouse.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BoltJuly 24, 2024 | markets.businessinsider.comBOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmJuly 22, 2024 | tmcnet.comBolt Biotherapeutics, Inc. (NASDAQ:BOLT) Q1 2024 Earnings Call TranscriptMay 19, 2024 | msn.comLeerink Partners Downgrades Bolt Biotherapeutics (BOLT)May 17, 2024 | msn.comGuggenheim Downgrades Bolt Biotherapeutics (BOLT)May 16, 2024 | msn.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeutics, Inc. - BOLTMay 15, 2024 | stockhouse.comBolt Biotherapeutics Inc (BOLT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts ...May 15, 2024 | finance.yahoo.comWall Street Set to Open Modestly Higher Wednesday as Inflation Dips in AprilMay 15, 2024 | msn.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bolt Biotherapeutics (BOLT), Laboratory (LH) and Biophytis (OtherBPTSY)May 15, 2024 | markets.businessinsider.comBolt Biotherapeutics draws downgrades after portfolio shakeupMay 15, 2024 | msn.comBOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | msn.comBolt Biotherapeutics’ Promising Trajectory in Immuno-Oncology: A Strong Buy RecommendationMarch 25, 2024 | markets.businessinsider.comVivo Opportunity Fund Holdings, L.P.'s Net WorthFebruary 9, 2024 | benzinga.comH.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)December 27, 2023 | markets.businessinsider.comIs Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?November 20, 2023 | finance.yahoo.comBolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 10, 2023 | finanznachrichten.deBolt Biotherapeutics to Present at Stifel 2023 Healthcare ConferenceNovember 7, 2023 | finance.yahoo.comBolt Biotherapeutics: Buy Rating Justified by Promising Clinical Results and Strong Financial OutlookOctober 24, 2023 | markets.businessinsider.comBolt Biotherapeutics: First Patient Dosed In Clinical Trial Of BDC-3042October 19, 2023 | markets.businessinsider.comBolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer's 2023 Annual MeetingOctober 18, 2023 | benzinga.comBolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual MeetingOctober 18, 2023 | finance.yahoo.comBolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023October 16, 2023 | finance.yahoo.comBolt Biotherapeutics' BDC-1001 Gets FDA Orphan Drug Designation To Treat Gastric CancersSeptember 28, 2023 | markets.businessinsider.comBolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042September 12, 2023 | finance.yahoo.comBolt Biotherapeutics Second Quarter 2023 Earnings: Misses ExpectationsAugust 9, 2023 | finance.yahoo.comBolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 8, 2023 | finance.yahoo.comBolt Biotherapeutics Initiates Phase 2 Clinical Studies of BDC-1001 in Patients With HER2-Positive CancerAugust 3, 2023 | finance.yahoo.comBolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023July 31, 2023 | finance.yahoo.comAfter COVID, a Continued Push for Diversity in Clinical TrialsJuly 19, 2023 | msn.comH.C. Wainwright Sticks to Their Buy Rating for Bolt Biotherapeutics (BOLT)June 5, 2023 | markets.businessinsider.comBioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseasesMay 30, 2023 | finance.yahoo.comBolt Biotherapeutics Highlights Comprehensive Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at 2023 ASCO Annual MeetingMay 25, 2023 | finance.yahoo.comBenzinga's Top Ratings Upgrades, Downgrades For May 12, 2023May 12, 2023 | msn.comBolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 11, 2023 | finance.yahoo.comLooking Into Bolt Biotherapeutics's Return On Capital EmployedMarch 30, 2023 | msn.comBolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare ConferenceFebruary 28, 2023 | finance.yahoo.comBolt Biotherapeutics to Present at February Investor ConferencesFebruary 1, 2023 | finance.yahoo.comBolt Biotherapeutics Appoints Laura Berner to Board of DirectorsDecember 14, 2022 | finance.yahoo.comBolt Biotherapeutics, Inc.: Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 13, 2022 | finanznachrichten.deBolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 10, 2022 | finance.yahoo.comBolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual MeetingNovember 7, 2022 | finance.yahoo.com Get Bolt Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. BOLT Media Mentions By Week BOLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOLT News Sentiment▼0.000.40▲Average Basic Materials News Sentiment BOLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOLT Articles This Week▼00▲BOLT Articles Average Week Get Bolt Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IVN News AFM News SKE News LAC News ALS News MDI News SLI News TECK.A News FVL News ETG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:BOLT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bolt Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BOLT Stock Alerts